21148313 | Peroxiredoxin II restrains DNA damage-induced death in cancer cells by positively regulating JNK-dependent DNA repair. | J Biol Chem | 2011 Mar 11 | Lee KW | doi: 10.1074/jbc.M110.179416 |
29258530 | Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer. | J Transl Med | 2017 Dec 19 | Lv Z | doi: 10.1186/s12967-017-1357-7. |
15936593 | Identification of differentially expressed proteins during human urinary bladder cancer progression. | Cancer Detect Prev | 2005 | Memon AA | - |
22207736 | Genome-wide analysis of histone H3 acetylation patterns in AML identifies PRDX2 as an epigenetically silenced tumor suppressor gene. | Blood | 2012 Mar 8 | Agrawal-Singh S | doi: 10.1182/blood-2011-06-358705 |
26636537 | Dimeric peroxiredoxins are druggable targets in human Burkitt lymphoma. | Oncotarget | 2016 Jan 12 | Trzeciecka A | doi: 10.18632/oncotarget.6435. |
29332450 | Identification and Comparison of Differentiation-Related Proteins in Hepatocellular Carcinoma Tissues by Proteomics. | Technol Cancer Res Treat | 2017 Dec | Zhao S | doi: 10.1177/1533034617732426 |
21539911 | Peroxiredoxin 2 in the nucleus and cytoplasm distinctly regulates androgen receptor activity in prostate cancer cells. | Free Radic Biol Med | 2011 Jul 1 | Shiota M | doi: 10.1016/j.freeradbiomed.2011.04.001 |
24234423 | Peroxiredoxin 2 is upregulated in colorectal cancer and contributes to colorectal cancer cells' survival by protecting cells from oxidative stress. | Mol Cell Biochem | 2014 Feb | Lu W | - |
22215146 | Polymorphisms of peroxiredoxin 1, 2 and 6 are not associated with esophageal cancer. | J Cancer Res Clin Oncol | 2012 Apr | Zhang B | doi: 10.1007/s00432-011-1119-5 |
19584157 | Identification of a new panel of serum autoantibodies associated with the presence of in situ carcinoma of the breast in younger women. | Clin Cancer Res | 2009 Jul 15 | Desmetz C | doi: 10.1158/1078-0432.CCR-08-3307 |
26021759 | An important role for peroxiredoxin II in survival of A549 lung cancer cells resistant to gefitinib. | Exp Mol Med | 2015 May 29 | Kwon T | doi: 10.1038/emm.2015.24. |
23113308 | Expression of peroxiredoxin 1, 2, 3, and 6 genes in cancer cells during drug resistance formation. | Bull Exp Biol Med | 2012 Oct | Kalinina EV | - |
24750185 | Induced nitric oxide synthetase and peroxiredoxin expression in intramucosal poorly differentiated gastric cancer of young patients. | Pathol Int | 2014 Apr | Hirahashi M | doi: 10.1111/pin.12152. |
24222118 | Human pancreatic cancer cells with acquired gemcitabine resistance exhibit significant up-regulation of peroxiredoxin-2 compared to sensitive parental cells. | Anticancer Res | 2013 Nov | Suenaga S | - |
19424615 | Expression of human peroxiredoxin isoforms in response to cervical carcinogenesis. | Oncol Rep | 2009 Jun | Kim K | - |
22537621 | Peroxiredoxins and tropomyosins as plasma biomarkers for lung cancer and asbestos exposure. | Lung Cancer | 2012 Aug | Rostila A | doi: 10.1016/j.lungcan.2012.03.024 |
28125800 | Peroxiredoxin 2 is associated with colorectal cancer progression and poor survival of patients. | Oncotarget | 2017 Feb 28 | Peng L | doi: 10.18632/oncotarget.14801. |
26866938 | Peroxiredoxin II Is Essential for Maintaining Stemness by Redox Regulation in Liver Cancer Cells. | Stem Cells | 2016 May | Kwon T | doi: 10.1002/stem.2323 |
27894099 | Peroxiredoxin 2 is essential for maintaining cancer stem cell-like phenotype through activation of Hedgehog signaling pathway in colon cancer. | Oncotarget | 2016 Dec 27 | Wang R | doi: 10.18632/oncotarget.13559. |
29422545 | Silencing of peroxiredoxin II by promoter methylation is necessary for the survival and migration of gastric cancer cells. | Exp Mol Med | 2018 Feb 9 | Hong SH | doi: 10.1038/emm.2017.267. |